🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Transgender In Transition

Recruitingn/aAges 18 Years - anyAllUniversitätsklinikum Hamburg-Eppendorf
NCT04028219 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5) * written informed consent following adequate oral and written Information * before gender-affirming hormonal treatment Exclusion Criteria: * pregnancy or breast-feeding
💊

What it tests

  • Online surveys
📍

Where

5 sites
Universitätsklinikum Frankfurt
Frankfurt am Main, Germany
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Medical Center of the Ludwig-Maximilians-University of Munich
Munich, Germany
Universitätsspital Basel
Basel, Switzerland
UniversitätsSpital Zürich
Zurich, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy